Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Gynecol Oncol. 2009 Jul 31;115(1):112–120. doi: 10.1016/j.ygyno.2009.06.031

Figure 5.

Figure 5

Figure 5

Quantitation of dot immunoblots presenting the immunoreactivity of sera from normal controls and women with pancreatic (n=15), lung (n=15), breast (n=15), colon (n=15), and ovarian cancers (n=40). * denotes significantly different (p<0.05) than control.